CD4+T cells participate in the anti-tumor immune response by secreting various cytokines and chemokines to recruit inflammatory cells and help activate CD8+T cells, while CD8+T cells mainly exert immunocidal effects through the perforin–granzyme pathway and the Fas-FasL pathway. This evidence concerns the gene PRF1 and neoplasm.